Actinium Pharmaceuticals

Price & Volume

Stats

Open	$1.21
Previous Close	$1.26
Day Range	$1.21-$1.26
52W Range	$1.02-$10.24
Market Cap	$39.3M
Shares Short	2M

Financials

Revenue (12 Mos)	$81,000
Revenue Growth (YoY)	-100%
Gross Profit (12 Mos)	$81,000
Diluted EPS	-$1.27

News

Yahoo Finance • 7 hours ago

ATNM Investors Have the Opportunity to Lead the Actinium Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Yahoo Finance • 20 hours ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Solaris, Actinium, Bakkt, and Cerevel and Encourages Investors to Contact the Firm

Yahoo Finance • 22 hours ago

Actinium Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 27, 2025 Deadline to file Lead Plaintiff Motion

Yahoo Finance • yesterday

The Gross Law Firm Notifies Actinium Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ATNM

About

CEO	Mr. Sandesh C. Seth M.B.A., M.S.
CFO	Mr. Steven O'Loughlin BS
Address	100 Park Avenue, New York, NY, United States, 10017
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	37